Add to Calendar 3/27/2019 8:15:00 AM 3/28/2019 2:30:00 PM 2019 Annual Meeting: State of Possible Conference
This year’s Annual Meeting is now the State of Possible Conference where we'll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. We'll also have a networking reception, the State of Possible Celebration, immediately following Day 1 of the conference, where we'll have great food, drinks, a DJ. Attendees will also have access to the exhibits at the Museum of Science. Join us as we celebrate the State of Possible!
 

If you haven’t attended our Annual Meeting before, it is the premier east coast life sciences conference and this year’s event is better than ever. With speakers like Katrine Bosley, John Maraganore, Jeremy Levin, George Church, and more, we have some of the brightest names in biotech talking about the issues impacting our industry. See our incredible lineup of speakers and topics below. Online registration closes at noon on Tuesday, March 26th. Walk-in registrations will be available on-site. 

Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142
Co-Founder, Director, President, and CEO | HC Bioscience
Leslie J. Williams is a seasoned biopharmaceutical leader with extensive experience in founding and leading biotech companies. As Co-Founder, President, and CEO of HC Bioscience, she is pioneering the development of new genetic medicines utilizing engineered tRNA to target nonsense mutations responsible for 10-15% of genetic diseases. Previously, Leslie was Founder and CEO of ImmusanT, advancing immunotherapies for autoimmune diseases. She has also served as CEO of Ventaira Pharmaceuticals, where she helped develop pulmonary drug delivery technology, and was a founding member of the team at INO Therapeutics, which developed a treatment for pulmonary hypertension. Leslie currently serves on the Board of Directors for Ocular Therapeutix (Nasdaq: OCUL), Windtree Therapeutics (Nasdaq: WINT), Biotechnology Innovation Organization (BIO), and CSCRI (Coral Sea Clinical Research Institute) as well as the Board of Advisors of Life Science Cares and the Editorial Advisory Board of Life Science Leader. She is also a founding Ambassador of BioBoost and a mentor at the GLG Institute. Williams holds an MBA from Washington University, John Olin School of Business and a bachelor’s degree nursing from the University of Iowa. Before entering the biopharmaceutical industry, Leslie was a critical care nurse at Duke University, Medical College of Virginia, and the University of Iowa. Leslie has been recognized for her contributions with numerous awards, including Distinguished Alumni and Honorary Alumni honors from the University of Iowa.

Brought to you by